 Genetic Engineering News | Electronics Giants Set Sights on Biotech Genetic Engineering News Last October, the company halted development of a biosimilar version of the Roche/Biogen Idec lymphoma and rheumatoid arthritis drug Rituxan (rituximab)—just six months after Tae-Han Kim, president of Samsung Biologics, told the Financial Times the ... |
